Pazopanib
- Product NDC
- 51407-872
- 11-digit product format
- 514070872
- Labeler code
- 51407
- Product ID
- 51407-872_445b5e3e-5de0-323d-e063-6394a90a5fae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pazopanib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA217713
- Marketing category
- ANDA
- Marketing start
- 2023-10-19
- Substance
- PAZOPANIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pazopanib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PAZOPANIB | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7RN5DR86CK |
| Rxcui | 867502 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51407-872-12 | Pazopanib | 120 in 1 BOTTLE | TABLET | 120 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51407-872 | PAZOPANIB TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 2 | Current NDC, 1 package rows | 20240328_115eb5bb-1403-fb3d-e063-6394a90ad320.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51407-872-12 | 51407087212 | 120 TABLET in 1 BOTTLE (51407-872-12) | 120 tablet | 2024-01-08 | No | No | Current |